Chronic Obstructive Pulmonary Disease (COPD) is a chronic and progressive lung disease characterized by irreversible airflow obstruction, airway inflammation , oxidative stress and, often, mucus hypersecretion. The aim of thisstudy is to determine if carbocisteine, a mucolytic and antioxidant agent, administered daily for 12 months, can reduce exacerbation frequency in COPD patients.
Effect of carbocisteine in prevention of exacerbation of chronic obstructive pulmonary disease (CAPRI study): an observational study / Esposito, Antonietta; Valentino, Maria Rosaria; Bruzzese, Dario; Bocchino, Marialuisa; Ponticiello, Antonio; Stanziola, ANNA AGNESE; SANDUZZI ZAMPARELLI, Alessandro. - In: PULMONARY PHARMACOLOGY & THERAPEUTICS. - ISSN 1094-5539. - (2016). [10.1016/j.pupt.2016.03.003]
Effect of carbocisteine in prevention of exacerbation of chronic obstructive pulmonary disease (CAPRI study): an observational study
BRUZZESE, DARIO;BOCCHINO, MARIALUISA;PONTICIELLO, ANTONIO;STANZIOLA, ANNA AGNESE;SANDUZZI ZAMPARELLI, ALESSANDRO
2016
Abstract
Chronic Obstructive Pulmonary Disease (COPD) is a chronic and progressive lung disease characterized by irreversible airflow obstruction, airway inflammation , oxidative stress and, often, mucus hypersecretion. The aim of thisstudy is to determine if carbocisteine, a mucolytic and antioxidant agent, administered daily for 12 months, can reduce exacerbation frequency in COPD patients.| File | Dimensione | Formato | |
|---|---|---|---|
|
Effects of carbocisteine.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
263.84 kB
Formato
Adobe PDF
|
263.84 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
